{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:01:24Z","timestamp":1794711684250,"version":"4.9.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Olive View UCLA Medical Center Department of Medicine"},{"DOI":"10.13039\/100011075","name":"David Geffen School of Medicine, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Harm reduction is an accumulation of strategies aimed at preventing adverse health outcomes associated with illicit substance use. Several harm reduction programs and services exist within Los Angeles County (LAC), however their success relies in part on the application of harm reduction principles by local primary care providers serving patients with substance use disorders. This study aims to assess the readiness of patient-centered medical homes in the San Fernando Valley to provide effective harm reduction to patients who use injection drugs and identify barriers to doing so.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An online survey was distributed to primary care providers and social workers via email at federally qualified health centers and LAC Department of Health Services clinics in the San Fernando Valley between May and June 2019. It consisted of 22 multiple-choice, Likert scale, and short answer questions. The survey assessed knowledge of injection drug use (IDU), familiarity and utilization of harm-reduction and resources, and self-evaluation of attitudes and skills.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were a total of 41 survey respondents across all clinics. Of respondents, 98% correctly identified heroin as a drug typically injected, and 93% identified Hepatitis C as an infectious risk of IDU. 63% of respondents use harm reduction strategies every few months or less. 34% prescribe buprenorphine routinely, and 76% prescribe pre-exposure prophylaxis to those at risk for Human Immunodeficiency Virus (HIV). 76% are comfortable discussing IDU with their patients, but 59% indicate that they lack the necessary skills, and 42% agree that they lack the time to address it.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Knowledge of IDU was adequate among those surveyed, although overall utilization of harm reduction was infrequent. There is a perceived deficit in skills and time to effectively provide harm reduction to primary care patients in the San Fernando Valley.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13690-022-00855-w","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T07:06:40Z","timestamp":1649228800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Harm reduction readiness for illicit IV drug use among safety-net primary care practices in the San Fernando Valley"],"prefix":"10.1186","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6800-306X","authenticated-orcid":false,"given":"Thomas","family":"Kalinoski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"DeWitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishikesh","family":"Belani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"855_CR1","unstructured":"Hedegaard H, Warner M, Mini\u00f1o AM, editors. Drug overdose deaths in the United States, 1999-2016. NCHS Data Brief, no 294. Hyattsville, MD: National Center for Health Statistics; 2017."},{"key":"855_CR2","volume-title":"Prescription Opioid Misuse\/Abuse and Consequences","author":"T Kim","year":"2019","unstructured":"Kim T. Prescription Opioid Misuse\/Abuse and Consequences. SAPC Data Brief: County of Los Angeles Public Health; 2019."},{"key":"855_CR3","unstructured":"Potential Complications Of IV Drug Use. UCLA Dual Diagnosis Program. https:\/\/www.semel.ucla.edu\/dual-diagnosisprogram\/News_and_Resources\/Potential_complications_Of_IV_Drug_Use. Published 2021. Accessed December 2, 2021."},{"key":"855_CR4","volume-title":"Managing HIV and hepatitis C outbreaks among people who inject drugs\u2014A guide for state and local health departments","author":"Centers for Disease Control and Prevention","year":"2018","unstructured":"Centers for Disease Control and Prevention. Managing HIV and hepatitis C outbreaks among people who inject drugs\u2014A guide for state and local health departments. 2018."},{"key":"855_CR5","unstructured":"Harm Reduction Coalition. https:\/\/harmreduction.org (2020). Accessed 17 Feb 2020."},{"key":"855_CR6","volume-title":"Harm reduction and syringe exchange programs in the city and county of Los Angeles","author":"S Simon","year":"2010","unstructured":"Simon S, Long A, Bluthenthal R. Harm reduction and syringe exchange programs in the city and county of Los Angeles. 2010. http:\/\/ens.lacity.org\/dod\/aids\/news\/dod_aidsnews109762841_01012010.pdf. Accessed 17 Feb 2020."},{"key":"855_CR7","unstructured":"California Hub and Spoke MAT Expansion Program. http:\/\/www.uclaisap.org\/ca-hubandspoke (2020). Accessed 17 Feb 2020."},{"key":"855_CR8","unstructured":"Casanova M. Resources & Referrals for the Service Provider. Homeless Health Care Los Angeles Resource Guide 2017. Los Angeles: Homeless Health Care Los Angeles; 2017."},{"issue":"5","key":"855_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1192\/bjp.164.5.660","volume":"164","author":"M Gossop","year":"1994","unstructured":"Gossop M, Griffiths P, Powis B, Strang J. Cocaine: patterns of use, route of administration, and severity of dependence. Br J Psychiatry. 1994;164(5):660\u20134.","journal-title":"Br J Psychiatry"},{"key":"855_CR10","volume-title":"Epidemiologic trends in drug abuse, community epidemiology work group","author":"National Institutes of Health, Division of Epidemiology and Prevention Research","year":"2014","unstructured":"National Institutes of Health, Division of Epidemiology and Prevention Research. Epidemiologic trends in drug abuse, community epidemiology work group. 2014."},{"key":"855_CR11","unstructured":"Belani H. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: Summary guidance from CDC and the U.S. Department of Health and Human Services. U.S Department of Health and Human Services, Centers for Disease Control and Prevention. 2012."}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-022-00855-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-022-00855-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-022-00855-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T07:10:20Z","timestamp":1649229020000},"score":1,"resource":{"primary":{"URL":"https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/s13690-022-00855-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1186\/s13690-022-00855-w","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"18 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Olive View-UCLA Education & Research Institute Institutional Review Board approved the survey. The participants were informed that their consent to participate in survey was completely voluntary, and that they would be allowed to withdraw from the survey at any time without consequence.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}